Press Release|Articles|July 30, 2025
Camber Launches Prucalopride Tablets
Listen
0:00 / 0:00
Key Takeaways
- Camber Pharmaceuticals introduces Prucalopride Tablets, a generic for Motegrity®, targeting chronic idiopathic constipation in adults.
- Chronic idiopathic constipation affects 10-17% of the global population, predominantly women and older adults.
Advertisement
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Prucalopride Tablets [proo-KAL-oh-pride] to its growing portfolio. Prucalopride Tablets are generic for Motegrity®.
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. CIC affects about 10-17% of the global population and is more commonly seen in women and older adults.
Prucalopride Tablets are available in 1 mg and 2 mg strengths in 30 count bottles.
To learn more about Prucalopride Tablets, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review
3
Carbachol and Brimonidine Tartrate Combination Eye Drop Receives FDA Approval for Presbyopia
4
Plant-Based Foods, Even If Ultra-Processed, Can Reduce Risk of Diabetes
5